News from biofourmis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 18, 2019, 07:00 ET Biofourmis Forms Alliance With Global Healthcare Company To Offer Digital Therapeutics For Patients With Heart Failure

Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has been selected by Novartis, a global...


Nov 18, 2019, 07:00 ET Biofourmis Announces Acquisition of Biovotion AG, Completing Biovitals® Platform to Deliver Precise Interventions at the Right Time to Manage Patients with Complex Chronic Conditions

Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has reached an agreement to acquire Zürich,...


Oct 03, 2019, 07:00 ET Biofourmis' Biovitals™ Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring

Biofourmis, a fast-growing global leader in digital therapeutics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...


Oct 02, 2019, 09:00 ET Biofourmis Named to the 2019 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups

CB Insights announced today at its Future of Health conference that Biofourmis, a Boston-based fast-growing global leader in digital therapeutics,...


Aug 22, 2019, 07:30 ET Biofourmis names two pharmaceutical veterans to leadership team

Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, has added two global pharmaceutical senior executive veterans to...


Jul 16, 2019, 07:55 ET Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)

Biofourmis, a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-Mayo Clinic Center of...


May 21, 2019, 08:00 ET Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Therapeutics Platform

Biofourmis, a fast-growing leader in digital therapeutics, today announced that it has successfully closed $35 million in Series B financing. The...


Apr 30, 2019, 17:00 ET Biofourmis' RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias

Biofourmis announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its RhythmAnalyticsTM platform, a...


Mar 13, 2019, 09:00 ET BiovitalsHF™, a Prescription Software Uses Data Science to Augment Guideline-directed Use of Heart Failure Therapies

Biofourmis, a fast-growing digital therapeutics company focused on augmenting personalized care and therapies to empower patients with complex...